Jason Patrick Meyenburg's most recent trade in Disc Medicine Inc was a trade of 123,600 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Disc Medicine Inc | Jason Patrick Meyenburg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 123,600 | 123,600 | - | - | Restricted Stock Units | |
| Disc Medicine Inc | Jason Patrick Meyenburg | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 9.46 per share. | 14 May 2021 | 13,000 | 13,000 | - | 9.5 | 122,929 | Common Stock |
| Disc Medicine Inc | Jason Patrick Meyenburg | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 1,124,832 | 1,124,832 | - | - | Stock Option (Right to Buy) |